Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Elicio Therapeutics, Inc. (ELTX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Elicio Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1601485.
Total stock buying since 2021: $8,215,803.
Total stock sales since 2021: $7,739,086.
Total stock option exercises since 2021: $1,680.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 0 | $0 | 381 | $1,680 |
| 2023 | 1,213,000 | $7,047,529 | 0 | $0 | 0 | $0 |
| 2022 | 102,896 | $126,459 | 0 | $0 | 0 | $0 |
| 2021 | 404,000 | $1,041,815 | 714,587 | $7,739,086 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 0 | $0 | 0 | $0 | 381 | $1,680 |
| 2023-12 | 1,213,000 | $7,047,529 | 0 | $0 | 0 | $0 |
| 2022-05 | 102,896 | $126,459 | 0 | $0 | 0 | $0 |
| 2021-12 | 404,000 | $1,041,815 | 150,809 | $519,967 | 0 | $0 |
| 2021-11 | 0 | $0 | 150,807 | $632,443 | 0 | $0 |
| 2021-10 | 0 | $0 | 803 | $6,934 | 0 | $0 |
| 2021-09 | 0 | $0 | 806 | $8,361 | 0 | $0 |
| 2021-08 | 0 | $0 | 826 | $8,192 | 0 | $0 |
| 2021-07 | 0 | $0 | 1,228 | $13,478 | 0 | $0 |
| 2021-06 | 0 | $0 | 793 | $10,497 | 0 | $0 |
| 2021-05 | 0 | $0 | 440 | $6,124 | 0 | $0 |
| 2021-04 | 0 | $0 | 780 | $11,150 | 0 | $0 |
| 2021-03 | 0 | $0 | 941 | $18,659 | 0 | $0 |
| 2021-02 | 0 | $0 | 406,354 | $6,503,281 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-16 | Demuth Peter (Chief Scientific Officer) | Option Ex | 381 | 4.41 | 1,680 |
| 2023-12-22 | Gkcc, Llc (10% Owner) | Buy | 1,213,000 | 5.81 | 7,047,529 |
| 2022-05-25 | Venkatesan Jay (See Remarks) | Buy | 11,313 | 1.25 | 14,107 |
| 2022-05-24 | Venkatesan Jay (See Remarks) | Buy | 32,200 | 1.24 | 39,928 |
| 2022-05-20 | Nissenson Allen | Buy | 2,037 | 1.18 | 2,403 |
| 2022-05-20 | Venkatesan Jay (See Remarks) | Buy | 50,000 | 1.23 | 61,500 |
| 2022-05-19 | Nissenson Allen | Buy | 7,346 | 1.16 | 8,521 |
| 2021-12-28 | Venkatesan Jay (See Remarks) | Buy | 210,337 | 2.66 | 559,917 |
| 2021-12-27 | Venkatesan Jay (See Remarks) | Buy | 66,907 | 2.55 | 170,545 |
| 2021-12-20 | Neylan John F. (See Remarks) | Sale | 358 | 2.62 | 937 |
| 2021-12-20 | Venkatesan Jay (See Remarks) | Buy | 3,527 | 2.54 | 8,976 |
| 2021-12-17 | Venkatesan Jay (See Remarks) | Buy | 13,742 | 2.54 | 34,959 |
| 2021-12-16 | Venkatesan Jay (See Remarks) | Buy | 27,883 | 2.55 | 70,990 |
| 2021-12-15 | Venkatesan Jay (See Remarks) | Buy | 77,604 | 2.41 | 186,948 |
| 2021-12-15 | Curhan Gregory S (See Remarks) | Buy | 4,000 | 2.37 | 9,480 |
| 2021-12-14 | Rhodes Jennifer J (See Remarks) | Sale | 451 | 2.42 | 1,090 |
| 2021-12-06 | Goldberg Itzhak (See Remarks) | Sale | 32,118 | 3.35 | 107,723 |
| 2021-12-03 | Goldberg Itzhak (See Remarks) | Sale | 40,215 | 3.39 | 136,208 |
| 2021-12-02 | Goldberg Itzhak (See Remarks) | Sale | 38,800 | 3.51 | 136,343 |
| 2021-12-01 | Goldberg Itzhak (See Remarks) | Sale | 38,867 | 3.54 | 137,666 |
| 2021-11-18 | Neylan John F. (See Remarks) | Sale | 374 | 4.13 | 1,544 |
| 2021-11-16 | Goldberg Itzhak (See Remarks) | Sale | 38,495 | 4.25 | 163,796 |
| 2021-11-15 | Goldberg Itzhak (See Remarks) | Sale | 111,505 | 4.17 | 465,198 |
| 2021-11-15 | Rhodes Jennifer J (See Remarks) | Sale | 433 | 4.40 | 1,905 |
| 2021-10-18 | Neylan John F. (See Remarks) | Sale | 373 | 8.62 | 3,215 |
| 2021-10-14 | Rhodes Jennifer J (See Remarks) | Sale | 430 | 8.65 | 3,719 |
| 2021-09-20 | Neylan John F. (See Remarks) | Sale | 376 | 10.07 | 3,786 |
| 2021-09-14 | Rhodes Jennifer J (See Remarks) | Sale | 430 | 10.64 | 4,575 |
| 2021-08-18 | Neylan John F. (See Remarks) | Sale | 381 | 9.03 | 3,440 |
| 2021-08-16 | Rhodes Jennifer J (See Remarks) | Sale | 445 | 10.68 | 4,752 |
| 2021-07-21 | Neylan John F. (See Remarks) | Sale | 365 | 10.98 | 4,007 |
| 2021-07-21 | Rhodes Jennifer J (See Remarks) | Sale | 432 | 10.94 | 4,726 |
| 2021-07-14 | Rhodes Jennifer J (See Remarks) | Sale | 431 | 11.01 | 4,745 |
| 2021-06-18 | Neylan John F. (See Remarks) | Sale | 366 | 13.20 | 4,831 |
| 2021-06-14 | Rhodes Jennifer J (See Remarks) | Sale | 427 | 13.27 | 5,666 |
| 2021-05-14 | Rhodes Jennifer J (See Remarks) | Sale | 440 | 13.92 | 6,124 |
| 2021-04-19 | Neylan John F. (See Remarks) | Sale | 381 | 13.55 | 5,162 |
| 2021-04-15 | Rhodes Jennifer J (See Remarks) | Sale | 399 | 15.01 | 5,988 |
| 2021-03-17 | Neylan John F. (See Remarks) | Sale | 442 | 19.13 | 8,455 |
| 2021-03-13 | Rhodes Jennifer J (See Remarks) | Sale | 499 | 20.45 | 10,204 |
| 2021-02-13 | Rhodes Jennifer J (See Remarks) | Sale | 457 | 19.54 | 8,929 |
| 2021-02-09 | Venkatesan Jay (See Remarks) | Sale | 159,177 | 16.00 | 2,546,832 |
| 2021-02-09 | Ganzi Victor F | Sale | 246,720 | 16.00 | 3,947,520 |
Insider trading activities including stock purchases, stock sales, and option exercises of ELTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Elicio Therapeutics, Inc. (symbol ELTX, CIK number 1601485) see the Securities and Exchange Commission (SEC) website.